Skip to main content
Top
Published in: BMC Neurology 1/2020

Open Access 01-12-2020 | Magnetic Resonance Imaging | Case report

A case report of severe tuberous sclerosis complex detected in utero and linked to a novel duplication in the TSC2 gene

Authors: Valérie Mongrain, Nicolaas H. van Doesburg, Françoise Rypens, Catherine Fallet-Bianco, Justine Maassen, Julien Dufort-Gervais, Lucie Côté, Philippe Major

Published in: BMC Neurology | Issue 1/2020

Login to get access

Abstract

Background

Disease severity is tremendously variable in tuberous sclerosis complex (TSC). In contrast with the detailed guidelines available for TSC diagnosis and management, clinical practice lacks adequate tools to evaluate the prognosis, especially in the case of in utero diagnosis. In addition, the correlation between genotypes and phenotypes remains a challenge, in part due to the large number of mutations linked to TSC. In this report, we describe a case of severe TSC diagnosed in utero and associated with a specific mutation in the gene tuberous sclerosis complex 2 (TSC2).

Case presentation

A mother was referred for a thorough investigation following the observation by ultrasound of cardiac abnormalities in her fetus. The mother was healthy and reported frequent, intense and long-lasting hiccups/spasms in the fetus. The fetus of gestational age 33 weeks and 4 days was found to have multiple cardiac tumors with cardiac ultrasound. Brain magnetic resonance imaging (MRI) performed in utero revealed the presence of sub-ependymal nodules and of abnormal signals disseminated in the white matter, in the cerebral cortex and in the cerebellum. Following diagnosis of definite TSC, pregnancy interruption was chosen by the parents. Genetic testing of the fetus exposed a duplication in exon 41 of TSC2 (c.5169dupA), which was absent in the parents. The autopsy ascertained the high severity of brain damage characterized by an extensive disorganisation of white and grey matter in most cerebral lobes.

Conclusions

This case presentation is the first to depict the association between a de novo TSC2 c.5169dupA and multi-organ manifestation together with indications of a particularly high disease severity. This report can help physicians to perform early clinical diagnosis of TSC and to evaluate the prognosis.
Literature
1.
go back to reference Ahlsén G, Gillberg IC, Lindblom R, Gillberg C. Tuberous sclerosis in Western Sweden. A population study of cases with early childhood onset. Arch Neurol. 1994;51(1):76–81.PubMedCrossRef Ahlsén G, Gillberg IC, Lindblom R, Gillberg C. Tuberous sclerosis in Western Sweden. A population study of cases with early childhood onset. Arch Neurol. 1994;51(1):76–81.PubMedCrossRef
2.
go back to reference Kristof AS, Zhi Li P, Major P, Landry JS. Lymphangioleiomyomatosis and tuberous sclerosis complex in Quebec: prevalence and health-care utilization. Chest. 2015;148(2):444–9.PubMedCrossRef Kristof AS, Zhi Li P, Major P, Landry JS. Lymphangioleiomyomatosis and tuberous sclerosis complex in Quebec: prevalence and health-care utilization. Chest. 2015;148(2):444–9.PubMedCrossRef
3.
go back to reference Welin KO, Carlqvist P, Svensson A, Althin R, Eklund E, Rask O. Epilepsy in tuberous sclerosis patients in Sweden - healthcare utilization, treatment, morbidity, and mortality using national register data. Seizure. 2017;53:4–9.PubMedCrossRef Welin KO, Carlqvist P, Svensson A, Althin R, Eklund E, Rask O. Epilepsy in tuberous sclerosis patients in Sweden - healthcare utilization, treatment, morbidity, and mortality using national register data. Seizure. 2017;53:4–9.PubMedCrossRef
4.
go back to reference Ebrahimi-Fakhari D, Mann LL, Poryo M, Graf N, von Kries R, Heinrich B, et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis. 2018;13(1):117.PubMedPubMedCentralCrossRef Ebrahimi-Fakhari D, Mann LL, Poryo M, Graf N, von Kries R, Heinrich B, et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis. 2018;13(1):117.PubMedPubMedCentralCrossRef
5.
go back to reference Jeong A, Wong M. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex. Epilepsia. 2016;57(9):1443–9.PubMedCrossRef Jeong A, Wong M. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex. Epilepsia. 2016;57(9):1443–9.PubMedCrossRef
6.
go back to reference Wilbur C, Sanguansermsri C, Chable H, Anghelina M, Peinhof S, Anderson K, et al. Manifestations of tuberous sclerosis complex: the experience of a provincial clinic. Can J Neurol Sci. 2017;44(1):35–43.PubMedCrossRef Wilbur C, Sanguansermsri C, Chable H, Anghelina M, Peinhof S, Anderson K, et al. Manifestations of tuberous sclerosis complex: the experience of a provincial clinic. Can J Neurol Sci. 2017;44(1):35–43.PubMedCrossRef
8.
go back to reference Rosset C, Netto CBO, Ashton-Prolla P. TSC1 and TSC2 gene mutations and their implications for treatment in tuberous sclerosis complex: a review. Genet Mol Biol. 2017;40(1):69–79.PubMedPubMedCentralCrossRef Rosset C, Netto CBO, Ashton-Prolla P. TSC1 and TSC2 gene mutations and their implications for treatment in tuberous sclerosis complex: a review. Genet Mol Biol. 2017;40(1):69–79.PubMedPubMedCentralCrossRef
9.
go back to reference Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68(1):64–80.PubMedCrossRef Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68(1):64–80.PubMedCrossRef
10.
go back to reference Kingswood C, Bolton P, Crawford P, Harland C, Johnson SR, Sampson JR, et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the clinical practice research Datalink (CPRD). Eur J Paediatr Neurol. 2016;20(2):296–308.PubMedCrossRef Kingswood C, Bolton P, Crawford P, Harland C, Johnson SR, Sampson JR, et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the clinical practice research Datalink (CPRD). Eur J Paediatr Neurol. 2016;20(2):296–308.PubMedCrossRef
11.
go back to reference de Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry. 2007;16(1):16–24.PubMedCrossRef de Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry. 2007;16(1):16–24.PubMedCrossRef
12.
go back to reference Muzykewicz DA, Newberry P, Danforth N, Halpern EF, Thiele EA. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav. 2007;11(4):506–13.PubMedCrossRef Muzykewicz DA, Newberry P, Danforth N, Halpern EF, Thiele EA. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav. 2007;11(4):506–13.PubMedCrossRef
13.
go back to reference Benova B, Petrak B, Kyncl M, Jezdik P, Maulisova A, Jahodova A, et al. Early predictors of clinical and mental outcome in tuberous sclerosis complex: a prospective study. Eur J Paediatr Neurol. 2018;22(4):632–41.PubMedCrossRef Benova B, Petrak B, Kyncl M, Jezdik P, Maulisova A, Jahodova A, et al. Early predictors of clinical and mental outcome in tuberous sclerosis complex: a prospective study. Eur J Paediatr Neurol. 2018;22(4):632–41.PubMedCrossRef
14.
go back to reference Wang YY, Pang LY, Ma SF, Zhang MN, Liu LY, Zou LP. Epilepsy may be the major risk factor of mental retardation in children with tuberous sclerosis: a retrospective cohort study. Epilepsy Behav. 2017;77:13–8.PubMedCrossRef Wang YY, Pang LY, Ma SF, Zhang MN, Liu LY, Zou LP. Epilepsy may be the major risk factor of mental retardation in children with tuberous sclerosis: a retrospective cohort study. Epilepsy Behav. 2017;77:13–8.PubMedCrossRef
15.
go back to reference Trickett J, Heald M, Oliver C, Richards C. A cross-syndrome cohort comparison of sleep disturbance in children with smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex. J Neurodev Disord. 2018;10(1):9.PubMedPubMedCentralCrossRef Trickett J, Heald M, Oliver C, Richards C. A cross-syndrome cohort comparison of sleep disturbance in children with smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex. J Neurodev Disord. 2018;10(1):9.PubMedPubMedCentralCrossRef
16.
go back to reference O'Callaghan FJ, Martyn CN, Renowden S, Noakes M, Presdee D, Osborne JP. Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch Dis Child. 2008;93(9):751–4.PubMedCrossRef O'Callaghan FJ, Martyn CN, Renowden S, Noakes M, Presdee D, Osborne JP. Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch Dis Child. 2008;93(9):751–4.PubMedCrossRef
17.
go back to reference Bolton PF, Clifford M, Tye C, Maclean C, Humphrey A, le Maréchal K, et al. Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the tuberous sclerosis 2000 study. Psychol Med. 2015;45(11):2321–31.PubMedCrossRef Bolton PF, Clifford M, Tye C, Maclean C, Humphrey A, le Maréchal K, et al. Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the tuberous sclerosis 2000 study. Psychol Med. 2015;45(11):2321–31.PubMedCrossRef
18.
go back to reference Mous SE, Overwater IE, Vidal Gato R, Duvekot J, Ten Hoopen LW, Lequin MH, et al. Cortical dysplasia and autistic trait severity in children with tuberous sclerosis complex: a clinical epidemiological study. Eur Child Adolesc Psychiatry. 2018;27(6):753–65.PubMedCrossRef Mous SE, Overwater IE, Vidal Gato R, Duvekot J, Ten Hoopen LW, Lequin MH, et al. Cortical dysplasia and autistic trait severity in children with tuberous sclerosis complex: a clinical epidemiological study. Eur Child Adolesc Psychiatry. 2018;27(6):753–65.PubMedCrossRef
19.
go back to reference Kaczorowska M, Jurkiewicz E, Domańska-Pakieła D, Syczewska M, Lojszczyk B, Chmielewski D, et al. Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex. Epilepsia. 2011;52(1):22–7.PubMedCrossRef Kaczorowska M, Jurkiewicz E, Domańska-Pakieła D, Syczewska M, Lojszczyk B, Chmielewski D, et al. Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex. Epilepsia. 2011;52(1):22–7.PubMedCrossRef
20.
go back to reference Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007;9(2):88–100.PubMedCrossRef Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007;9(2):88–100.PubMedCrossRef
21.
go back to reference Overwater IE, Swenker R, van der Ende EL, Hanemaayer KB, Hoogeveen-Westerveld M, van Eeghen AM, et al. Genotype and brain pathology phenotype in children with tuberous sclerosis complex. Eur J Hum Genet. 2016;24(12):1688–95.PubMedPubMedCentralCrossRef Overwater IE, Swenker R, van der Ende EL, Hanemaayer KB, Hoogeveen-Westerveld M, van Eeghen AM, et al. Genotype and brain pathology phenotype in children with tuberous sclerosis complex. Eur J Hum Genet. 2016;24(12):1688–95.PubMedPubMedCentralCrossRef
22.
go back to reference Humphrey A, Higgins JN, Yates JR, Bolton PF. Monozygotic twins with tuberous sclerosis discordant for the severity of developmental deficits. Neurology. 2004;62(5):795–8.PubMedCrossRef Humphrey A, Higgins JN, Yates JR, Bolton PF. Monozygotic twins with tuberous sclerosis discordant for the severity of developmental deficits. Neurology. 2004;62(5):795–8.PubMedCrossRef
23.
go back to reference Curatolo P, Moavero R, Roberto D, Graziola F. Genotype/phenotype correlations in tuberous sclerosis complex. Semin Pediatr Neurol. 2015;22(4):259–73.PubMedCrossRef Curatolo P, Moavero R, Roberto D, Graziola F. Genotype/phenotype correlations in tuberous sclerosis complex. Semin Pediatr Neurol. 2015;22(4):259–73.PubMedCrossRef
24.
go back to reference Dufner Almeida LG, Nanhoe S, Zonta A, Hosseinzadeh M, Kom-Gortat R, Elfferich P, et al. Comparison of the functional and structural characteristics of rare TSC2 variants with clinical and genetic findings. Hum Mutat. 2020;41(4):759–73. Dufner Almeida LG, Nanhoe S, Zonta A, Hosseinzadeh M, Kom-Gortat R, Elfferich P, et al. Comparison of the functional and structural characteristics of rare TSC2 variants with clinical and genetic findings. Hum Mutat. 2020;41(4):759–73.
25.
go back to reference Jozwiak J, Jozwiak S, Wlodarski P. Possible mechanisms of disease development in tuberous sclerosis. Lancet Oncol. 2008;9(1):73–9.PubMedCrossRef Jozwiak J, Jozwiak S, Wlodarski P. Possible mechanisms of disease development in tuberous sclerosis. Lancet Oncol. 2008;9(1):73–9.PubMedCrossRef
26.
go back to reference Dragoumi P, O'Callaghan F, Zafeiriou DI. Diagnosis of tuberous sclerosis complex in the fetus. Eur J Paediatr Neurol. 2018;22(6):1027–34.PubMedCrossRef Dragoumi P, O'Callaghan F, Zafeiriou DI. Diagnosis of tuberous sclerosis complex in the fetus. Eur J Paediatr Neurol. 2018;22(6):1027–34.PubMedCrossRef
27.
go back to reference Salussolia CL, Klonowska K, Kwiatkowski DJ, Sahin M. Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex. Annu Rev Genomics Hum Genet. 2019;20:217–40.PubMedCrossRef Salussolia CL, Klonowska K, Kwiatkowski DJ, Sahin M. Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex. Annu Rev Genomics Hum Genet. 2019;20:217–40.PubMedCrossRef
28.
go back to reference Kothare SV, Singh K, Chalifoux JR, Staley BA, Weiner HL, Menzer K, et al. Severity of manifestations in tuberous sclerosis complex in relation to genotype. Epilepsia. 2014;55(7):1025–9.PubMedCrossRef Kothare SV, Singh K, Chalifoux JR, Staley BA, Weiner HL, Menzer K, et al. Severity of manifestations in tuberous sclerosis complex in relation to genotype. Epilepsia. 2014;55(7):1025–9.PubMedCrossRef
29.
go back to reference Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Exome aggregation consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.PubMedPubMedCentralCrossRef Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Exome aggregation consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.PubMedPubMedCentralCrossRef
30.
go back to reference Ray CL, Grangé G. Routine third trimester ultrasound in low risk pregnancy confers no benefit!: AGAINST: Arguments for a routine third trimester ultrasound: what the meta-analysis does not show! BJOG. 2016;123(7):1122.PubMedCrossRef Ray CL, Grangé G. Routine third trimester ultrasound in low risk pregnancy confers no benefit!: AGAINST: Arguments for a routine third trimester ultrasound: what the meta-analysis does not show! BJOG. 2016;123(7):1122.PubMedCrossRef
31.
go back to reference Słowińska M, Jóźwiak S, Peron A, Borkowska J, Chmielewski D, Sadowski K, et al. Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures? Orphanet J Rare Dis. 2018;13(1):25.PubMedPubMedCentralCrossRef Słowińska M, Jóźwiak S, Peron A, Borkowska J, Chmielewski D, Sadowski K, et al. Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures? Orphanet J Rare Dis. 2018;13(1):25.PubMedPubMedCentralCrossRef
32.
go back to reference Jóźwiak S, Kotulska K, Domańska-Pakieła D, Lojszczyk B, Syczewska M, Chmielewski D, et al. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol. 2011;15(5):424–31.PubMedCrossRef Jóźwiak S, Kotulska K, Domańska-Pakieła D, Lojszczyk B, Syczewska M, Chmielewski D, et al. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol. 2011;15(5):424–31.PubMedCrossRef
33.
go back to reference Goel R, Aggarwal N, Lemmon ME, Bosemani T. Fetal and maternal manifestations of tuberous sclerosis complex: value of fetal MRI. Neuroradiol J. 2016;29(1):57–60.PubMedPubMedCentralCrossRef Goel R, Aggarwal N, Lemmon ME, Bosemani T. Fetal and maternal manifestations of tuberous sclerosis complex: value of fetal MRI. Neuroradiol J. 2016;29(1):57–60.PubMedPubMedCentralCrossRef
34.
go back to reference Jesmanas S, Norvainytė K, Gleiznienė R, Šimoliūnienė R, Endzinienė M. Different MRI-defined tuber types in tuberous sclerosis complex: quantitative evaluation and association with disease manifestations. Brain Dev. 2018;40(3):196–204. Jesmanas S, Norvainytė K, Gleiznienė R, Šimoliūnienė R, Endzinienė M. Different MRI-defined tuber types in tuberous sclerosis complex: quantitative evaluation and association with disease manifestations. Brain Dev. 2018;40(3):196–204.
35.
go back to reference Chu-Shore CJ, Major P, Montenegro M, Thiele E. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Neurology. 2009;72(13):1165–9.PubMedCrossRef Chu-Shore CJ, Major P, Montenegro M, Thiele E. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Neurology. 2009;72(13):1165–9.PubMedCrossRef
37.
go back to reference Lee JM, Kim JH, Choi SH. Tuberous sclerosis complex case series with novel duplication mutations of TSC2. Clin Neurol Neurosurg. 2019;186:105498.PubMedCrossRef Lee JM, Kim JH, Choi SH. Tuberous sclerosis complex case series with novel duplication mutations of TSC2. Clin Neurol Neurosurg. 2019;186:105498.PubMedCrossRef
38.
go back to reference Aw F, Goyer I, Raboisson MJ, Boutin C, Major P, Dahdah N. Accelerated cardiac rhabdomyoma regression with everolimus in infants with tuberous sclerosis complex. Pediatr Cardiol. 2017;38(2):394–400.PubMedCrossRef Aw F, Goyer I, Raboisson MJ, Boutin C, Major P, Dahdah N. Accelerated cardiac rhabdomyoma regression with everolimus in infants with tuberous sclerosis complex. Pediatr Cardiol. 2017;38(2):394–400.PubMedCrossRef
39.
go back to reference Birca A, Mercier C, Major P. Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex. J Neurosurg Pediatr. 2010;6(4):381–4.PubMedCrossRef Birca A, Mercier C, Major P. Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex. J Neurosurg Pediatr. 2010;6(4):381–4.PubMedCrossRef
40.
go back to reference Goyer I, Dahdah N, Major P. Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex. Pediatr Neurol. 2015;52(4):450–3.PubMedCrossRef Goyer I, Dahdah N, Major P. Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex. Pediatr Neurol. 2015;52(4):450–3.PubMedCrossRef
41.
go back to reference Mlczoch E, Hanslik A, Luckner D, Kitzmüller E, Prayer D, Michel-Behnke I. Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus. Ultrasound Obstet Gynecol. 2015;45(5):618–21.PubMedCrossRef Mlczoch E, Hanslik A, Luckner D, Kitzmüller E, Prayer D, Michel-Behnke I. Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus. Ultrasound Obstet Gynecol. 2015;45(5):618–21.PubMedCrossRef
Metadata
Title
A case report of severe tuberous sclerosis complex detected in utero and linked to a novel duplication in the TSC2 gene
Authors
Valérie Mongrain
Nicolaas H. van Doesburg
Françoise Rypens
Catherine Fallet-Bianco
Justine Maassen
Julien Dufort-Gervais
Lucie Côté
Philippe Major
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2020
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-020-01905-y

Other articles of this Issue 1/2020

BMC Neurology 1/2020 Go to the issue